Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2010
10/07/2010US20100255029 Newcastle disease virus vectored avian vaccines
10/07/2010US20100255028 Flavivirus Vaccine Vector Against Influenza Virus
10/07/2010US20100255027 Papilloma pseudovirus and preparation
10/07/2010US20100255026 Methods and compositions relating to anthrax spore glycoproteins as vaccines
10/07/2010US20100255022 Vaccine against clostridium perfringens
10/07/2010US20100255021 Truncated l1 protein of human papillomavirus type 6
10/07/2010US20100255016 Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
10/07/2010US20100255015 Pharmaceuticals compositions comprising actinomycete glycerol acyl derivatives antigens, their process of extraction, and their use against tuberculosis
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255006 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
10/07/2010US20100255003 Immune Disease Medicament Comprising a Modulator of the Binding Between a Heparin Bindin Domain of Thrombospondin-1 and a Beta1 Integrin
10/07/2010US20100255002 Immunogenic compositions for chlamydia trachomatis
10/07/2010US20100255001 Blockers of serotonin and its receptors for the treatment of hepatitis
10/07/2010US20100254995 Polypeptides, antibody variable domains and antagonists
10/07/2010US20100254987 Engineered proteins with high affinity for dota chelates
10/07/2010US20100254986 Method for making heteromultimeric polypeptides
10/07/2010US20100254985 Protein Formulations
10/07/2010US20100254981 Secreted/Cell Bound Poxvirus Proteins and Methods of Use Thereof as Vaccines and Anti-Viral Agents
10/07/2010US20100254963 Peg-modified arginine/lysine oxidoreductase
10/07/2010US20100254958 Antigen-Specific T-Cell Preparations from Bone Marrow
10/07/2010US20100254950 Bacteriophage or lytic protein derived from the bacteriophage which effective for the treatment of staphylococcus aureus biofilm
10/07/2010US20100254947 SIMIAN SUBFAMILY B ADENOVIRUSES SAdV-28, -27, -29, -32, -33, AND -35 AND USES THEREOF
10/07/2010US20100254944 Albumin Fusion Proteins
10/07/2010US20100254942 Hepatitis c antiviral compositions and methods
10/07/2010US20100254941 Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
10/07/2010US20100254940 Compositions and Methods for Regulating an Immune Response in a Subject
10/07/2010US20100254928 Novel composition containing ozonized surfactant
10/07/2010US20100254925 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and use thereof as an antimicrobial active ingredient
10/07/2010US20100254919 Topical Turmeric Skin Care Products
10/07/2010US20100254900 Biocompatible polymers and Methods of use
10/07/2010US20100252050 Delivery system
10/07/2010CA2757306A1 Formulation
10/07/2010CA2757240A1 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010CA2756873A1 Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
10/07/2010CA2755878A1 Inhibition of biofilm organisms
10/07/2010CA2753658A1 Anti-biofilm carbonate compounds for use in oral care compositions
10/07/2010CA2749512A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and use thereof
10/06/2010EP2236629A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
10/06/2010EP2236608A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
10/06/2010EP2236521A1 Y-type polyethylene glycol modified g-csf and preparation method and use thereof
10/06/2010EP2236515A1 Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236149A1 Medicinal composition
10/06/2010EP2236148A1 Medicinal agent for anti-helicobacter therapy
10/06/2010EP2236143A1 Antimicrobial agent for gram-positive bacteria
10/06/2010EP2236141A1 siDNA oligonucleotide as antiviral agent against Herpes virus Infections
10/06/2010EP2235057A2 G immunoglobulin used against anthrax toxins
10/06/2010EP2235041A2 Antimicrobial compounds
10/06/2010EP2235034A2 Immunomodulatory agents and methods of use
10/06/2010EP2235031A2 Synthesis of novel neamine derivatives and use thereof as antibacterial agents
10/06/2010EP2235030A1 Compound of the disaccharide type composition comprising and method for producing such a compound
10/06/2010EP2235018A1 Pharmaceutically acceptable salts of methyl (3-{ ýý3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl¨(3- morpholin-4-ylpropyl) amino¨methyl }phenyl) acetate and their use in therapy
10/06/2010EP2235015A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
10/06/2010EP2235008A2 Amide compounds as boosters of antivirals
10/06/2010EP2234977A1 Viral polymerase inhibitors
10/06/2010EP2234967A1 Compounds from mycelium of antrodia cinnamomea and use thereof
10/06/2010EP2234643A2 Composition for treatment of tuberculosis
10/06/2010EP1987038B1 Hcv ns5b inhibitors
10/06/2010EP1784492B1 Multiple rna polymerase iii promoter expression constructs
10/06/2010EP1637132B1 External preparation for athlete´s foot treatment
10/06/2010EP1513543B1 Fas peptide mimetics and uses thereof
10/06/2010EP1296951B1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010CN201598786U 矿盐板 Rock salt plates
10/06/2010CN1927284B Pharmaceutical formulation for treating chronic bacterial infection and method of preparing the same
10/06/2010CN1899438B Miao medicine powder for curing eczema and rubella
10/06/2010CN1887350B Recombinant vaccine and its use
10/06/2010CN1863524B Neutralizing agent for cavitating toxin
10/06/2010CN1857220B Slow released antituberculotic preparation
10/06/2010CN1829512B Medicinal composition containing triazole compound
10/06/2010CN1799575B Chinese medicinal dispersible tablet, its preparation process and ingredient detection method
10/06/2010CN1690047B 9-substituted minocycline compounds
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1646684B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
10/06/2010CN1626076B Andrographolide drop pills and preparation method
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN1520300B Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/06/2010CN101855349A West nile virus vaccine, and method for production thereof
10/06/2010CN101855238A Fusion protein vaccine
10/06/2010CN101854950A Donor specific antibody libraries
10/06/2010CN101854936A Dose forms comprising VX- 950 and their dosage regimen
10/06/2010CN101854927A Use of anti-bacterial compounds having an anaesthetic effect
10/06/2010CN101851636A Recombinant influenza viruses for vaccines and gene therapy
10/06/2010CN101851631A Codon-optimized EV71 VP1 gene and nucleic acid vaccine
10/06/2010CN101851627A Gene encoding protein of eriocheir sinensis cysteine protease inhibitor Escystatin and application
10/06/2010CN101851621A Microbial molecular marker and construction and application thereof
10/06/2010CN101851609A Porcine parvovirus L strain and use thereof in preparation of porcine parvovirus inactivated vaccines
10/06/2010CN101851304A Production process for manufacturing solid-phase povidone iodine
10/06/2010CN101851299A Preparation method of Kappa-carrageenan succinyl derivative
10/06/2010CN101851280A Plectasin mature polypeptide dimer fusion protein and preparation method thereof
10/06/2010CN101851279A Pseudomonas aeruginosa antigens
10/06/2010CN101851274A Polypeptides for suppressing invasion of hepatitis C virus
10/06/2010CN101851270A Polymyxin derivative and preparation method thereof
10/06/2010CN101851248A Method for preparing ceftizoxime pivoxil
10/06/2010CN101851240A Ganciclovir purification process
10/06/2010CN101851198A Preparation method of ciprofloxacin hydrochloride
10/06/2010CN101851196A 2-(1H) quinolinone derivative, medical composition, preparation method and application thereof
1 ... 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 ... 1798